Xeljanz has been FDA-approved since 2012 for ... Randy Beranek, president and CEO of the US-based National Psoriasis Foundation, said: “Psoriatic arthritis is a serious and debilitating chronic ...

Patients treated with tofacitinib experienced significantly fewer disease flares compared with placebo. The Food and Drug Administration (FDA) has approved Xeljanz® (tofacitinib; Pfizer) for the ...

“We are proud to offer Xeljanz, a treatment option for ankylosing ... Mission and Strategic Initiatives of the Arthritis Foundation. “With this approval, physicians and patients now have ...

Researchers found that more than 50 percent of 66 patients treated with the drug Xeljanz (tofacitinib citrate) saw hair regrowth in three months. “There is hope now that we will have more to ...

Schoenebaum estimates Xeljanz has potential to generate sales in psoriasis of about $1 billion worldwide. Pfizer said it expects results from five psoriasis clinical studies will provide the ...

Xeljanz is available as 5mg tablets in 28-, 60-, and 180-count bottles. For more information call (800) 438-1985 or visit Xeljanz.com . Latest News Your top articles for Thursday ...

The brand name will be Xeljanz. Timothy Anderson, the pharmaceuticals analyst at Bernstein Research, forecasts annual sales that will eventually hit $2.5 billion. The drug, one of the most ...

Pfizer’s(NYSE: PFE) Rheumatoid Arthritis drug ~ Xeljanz ~ is a relatively small drug with sales of around $2 billion, and it accounts for around 4% of the total rheumatoid arthritis drugs market.

NEW YORKThe Food and Drug Administration has approved Pfizer's rheumatoid arthritis pill Xeljanz, seen as potential big seller for the world's largest pharmaceutical company. Pfizer Inc. says the ...

Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved XELJANZ® XR (tofacitinib) extended-release 11 mg and 22 mg tablets for the once-daily ...

Xeljanz is one of Pfizer’s leading innovative health brands, accounting for $1.77 billion of Pfizer’s $53.65 billion in revenue last year. Photo: dominick reuter/Agence France-Presse/Getty Images ...